Pfizer, which in May officially abandoned its bid to buy British rival AstraZeneca, reported higher-than-expected second-quarter earnings, helped by growing sales of its cancer medicines.
via NYT > Business Day http://ift.tt/WLmfN2
via WordPress http://ift.tt/1lRoCDs
No comments:
Post a Comment